Evidence Summary
- Product
- Baronsie Ectoin Cream
- Regulatory record
- Functional Cosmetic Review Result Notice
- Reviewing authority
- National Institute of Food and Drug Safety Evaluation (NIFDS)
- Issue date
- July 22, 2025
- Receipt number
- 20250091954
- Result notice number
- 32739-1
- Reviewed efficacy statement
- Helps improve itching and related discomfort by supporting the recovery of skin barrier function.
- Principal ingredient listed in the review record
- Dexpanthenol, 0.20 g per 100 g
- Ectoin in the formula
- 1.00 g per 100 g, listed as a skin-conditioning agent
What Does “Completed Korea’s Functional Cosmetic Review” Mean?
IDNK Co., Ltd. submitted the functional cosmetic review request for Baronsie Ectoin Cream on May 19, 2025.
After reviewing the submission, the National Institute of Food and Drug Safety Evaluation issued the completion letter and the Functional Cosmetic Review Result Notice on July 22, 2025.
The record confirms the reviewed efficacy statement for this product under Korea’s functional cosmetic system.
What Efficacy Statement Was Reviewed?
The official Korean wording is:
피부장벽의 기능을 회복하여 가려움 등의 개선에 도움을 준다.
A source-locked English rendering is:
Helps improve itching and related discomfort by supporting the recovery of skin barrier function.
This is one connected efficacy statement. It should not be divided into two separate review claims.
How Should the Skin Barrier Wording Be Read?
The statement connects skin barrier function with itching and related discomfort. It describes support for improvement through the recovery of skin barrier function.
The reviewed wording applies to Baronsie Ectoin Cream and remains tied to this product’s regulatory record.
Which Ingredient Is Listed as the Principal Ingredient?
The official review record lists dexpanthenol as the principal ingredient at 0.20 g per 100 g of product.
The same record lists ectoin at 1.00 g per 100 g and classifies it as a skin-conditioning agent.
This distinction matters because the product name contains “Ectoin,” but the review record does not list ectoin as the principal functional ingredient.
Who Issued the Review Result?
The Functional Cosmetic Review Result Notice was issued by the National Institute of Food and Drug Safety Evaluation under Korea’s Ministry of Food and Drug Safety.
The completion letter states that the submitted review request was examined and found suitable, after which the result notice was issued.
Frequently Asked Questions
Is Baronsie Ectoin Cream a functional cosmetic in Korea?
Yes. Baronsie Ectoin Cream completed Korea’s functional cosmetic review, and the result notice was issued on July 22, 2025.
What efficacy statement was reviewed for Baronsie Ectoin Cream?
The reviewed statement says that the product helps improve itching and related discomfort by supporting the recovery of skin barrier function.
Who issued the review result?
The National Institute of Food and Drug Safety Evaluation under Korea’s Ministry of Food and Drug Safety issued the review result notice.
When was the review result issued?
The review completion letter and result notice were issued on July 22, 2025.
Is ectoin listed as the principal functional ingredient in the review record?
No. The review record lists dexpanthenol at 0.20 g per 100 g as the principal ingredient. Ectoin is listed at 1.00 g per 100 g as a skin-conditioning agent.
Does Baronsie Ectoin Cream treat atopic dermatitis?
No. Baronsie Ectoin Cream is a functional cosmetic, not a medicine. Its reviewed efficacy statement concerns support for improving itching and related discomfort through the recovery of skin barrier function.
Record Sources
- National Institute of Food and Drug Safety Evaluation. Functional Cosmetic Review Completion Letter for Baronsie Ectoin Cream. Receipt No. 20250091954. Issued July 22, 2025.
- National Institute of Food and Drug Safety Evaluation. Functional Cosmetic Review Result Notice for Baronsie Ectoin Cream. Result Notice No. 32739-1; Registration No. 32739; Item Standard Code 202501859. Issued July 22, 2025.
